Method of measuring efficacy of treatment for multiple sclerosis

US10420503B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10420503-B2
Application numberUS-201615282364-A
CountryUS
Kind codeB2
Filing dateSep 30, 2016
Priority dateSep 30, 2016
Publication dateSep 24, 2019
Grant dateSep 24, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of measuring efficacy of treatment of multiple sclerosis (MS) in an animal in a vivarium is described. Animal activity data is collected at multiple times during the night. Sequential time regions of the night are identified as high-activity, activity-drop, or low-activity regions. Embodiments are described to quantify a drop, during the night, of an animal's activity level. These quantified activity-drop scalars for consecutive nights are accumulated in an animal health dataset. This dataset is compared to healthy animals or a standard of care to determine efficacy. One embodiment quantifies an activity-drop by fitting straight-line curves through the data in the three nightly regions. Another embodiment uses a Fourier transform on a circle and a linear combination. Another embodiment compares areas under data curves in the regions. Animals may be housed in cages with other animals.

First claim

Opening claim text (preview).

We claim: 1. A method of measuring efficacy of a first treatment of multiple sclerosis (MS) in an animal in a vivarium comprising the steps of: (a) placing a study animal in a cage in the vivarium and enrolling the study animal in a study; (b) electronically observing one or more animal activities in real-time of the study animal using a combination of electronic cameras, infrared (IR) lighting of the study animals, and electronic hardware including computation and communication hardware; (c) selecting a single “LASSO metric” with an associated scalar “activity-drop value”; (d) selecting an “MS health detection function,” wherein an input to the MS health detection function comprises an animal health dataset; and wherein an output of the MS health detection function comprises an animal health severity scalar for the animal; (e) collecting a set of nightly activity data for the animal comprising a plurality of activity scalars for the animal each night, wherein the nightly activity scalars are collected repeatedly and continually throughout a night; (f) computing a LASSO best-fit of a first piece-wise linear function to the nightly activity data, generating a LASSO L0, L1 and L2; (g) applying the LASSO metric to the generated LASSO L0, L1 and L2, generating a nightly activity-drop value; (h) adding the nightly activity-drop value into the “animal health dataset,” wherein the animal health dataset comprises the nightly activity-drop values; (i) applying the MS health detection function to the animal health dataset; (j) iterating steps (f) through (h) for sequential nights until a terminating condition is reached; wherein a first measured efficacy of the first treatment comprises comparing the animal health severity scalars from step (i) to animal health severity scalars from a reference treatment; (k) removing the study animal from the study when the terminating condition is reached. 2. The method of claim 1 wherein: the first piece-wise linear function comprises two linear pieces; and wherein the nightly activity-drop value comprises a linear combination of LASSO L0, L1 and L2. 3. The method of claim 1 wherein: the first piece-wise linear function comprises three linear pieces; and wherein the nightly activity-drop value comprises a linear combination of LASSO L0, L1 and L2.

Assignees

Inventors

Classifications

  • Subject matter not provided for in other groups of this subclass · CPC title

  • using Fourier transforms · CPC title

  • Monitoring progression or stage of a disease · CPC title

  • Monitoring or measuring activity · CPC title

  • Cages for laboratory animals; Cages for measuring metabolism of animals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10420503B2 cover?
A method of measuring efficacy of treatment of multiple sclerosis (MS) in an animal in a vivarium is described. Animal activity data is collected at multiple times during the night. Sequential time regions of the night are identified as high-activity, activity-drop, or low-activity regions. Embodiments are described to quantify a drop, during the night, of an animal's activity level. These quan…
Who is the assignee on this patent?
Vium Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/4848. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).